Thar Pharmaceuticals Withdrawn, Nasdaq: THAR

Developing novel oral therapies for chronic pain utilizing the 505(b)(2) pathway.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

Developing novel oral therapies for chronic pain utilizing the 505(b)(2) pathway.
more less
IPO News for Thar Pharmaceuticals
more
IPO Data
IPO File Date 08/19/2016
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $50
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $50
Underwriters
more
Company Data
Headquarters Pittsburgh, PA
Founded 2006
Employees 4
Website www.tharpharma.com